Genmab, DK0010272202

Genmab stock after-hours at EUR 308.25: minus 1.99 percent versus Lang & Schwarz prior close

Published on 10/01/2026 at 18:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Genmab's after-hours price was EUR 308.25 at 6:00 p.m. CEST on October 1, 2026. Lang & Schwarz showed a minus 1.99 percent change versus the prior close.

Fotorealistisches Biotech-Labor mit Forschern in weißen Kitteln bei Antikörperforschung
Genmab A/S entwickelt Antikörpertherapien in modernen Biotech-Laboren mit Forschern und Präzisionsgeräten, Aktie DK0010272202, Illustration mit AI erstellt.

Genmab stock was at the after-hours price of EUR 308.25 at 6:00 p.m. CEST on October 1, 2026, showing a minus 1.99 percent change versus the Lang & Schwarz prior close of EUR 314.50 on September 30, 2026.

Trading after the Xetra close

The Lang & Schwarz quote showed a bid of EUR 307.30 and an ask of EUR 309.20 at the cited time. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Genmab stock.

Employee awards announced

In a September 24, 2026 company announcement, Genmab said its board had approved 13,794 restricted stock units and 13,331 warrants for employees of Genmab A/S and its subsidiaries. The restricted stock units and warrants have a stated value or exercise price of DKK 2,268, and both instruments vest over three years.

Extraordinary general meeting scheduled

Genmab A/S also announced that it will hold an extraordinary general meeting on October 7, 2026, at 3:00 p.m. CEST at its offices in Valby, Denmark. The notice was published by GlobeNewswire.

Disclaimer...

en | DK0010272202 | GENMAB | boerse | 70211648 | bgmi